The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
trans-2-amino-5-(-4-((S)-5,5-dimethyl-2-oxo-4-phenyloxazolidin-3-yl)cyclohexyl)nicotinonitrile ID: ALA3099718
PubChem CID: 72724967
Max Phase: Preclinical
Molecular Formula: C23H26N4O2
Molecular Weight: 390.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(C#N)c3)CC2)[C@H]1c1ccccc1
Standard InChI: InChI=1S/C23H26N4O2/c1-23(2)20(16-6-4-3-5-7-16)27(22(28)29-23)19-10-8-15(9-11-19)18-12-17(13-24)21(25)26-14-18/h3-7,12,14-15,19-20H,8-11H2,1-2H3,(H2,25,26)/t15-,19-,20-/m0/s1
Standard InChI Key: SOHHQHWGZGODEC-YSSFQJQWSA-N
Molfile:
RDKit 2D
29 32 0 0 1 0 0 0 0 0999 V2000
5.4245 -0.8861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9546 -1.9903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6470 -2.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2067 -3.2906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7390 -2.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8437 -3.7801 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8991 0.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1969 1.5045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1945 3.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2328 3.6062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8943 3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5965 3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8919 5.2533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8900 6.4533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9492 -0.8772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2501 0.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2134 1.6699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6300 3.1109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0862 3.4706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1259 2.3894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7093 0.9484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 2 0
5 7 1 0
8 7 1 1
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 8 1 0
11 14 1 6
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
17 19 1 0
19 20 2 0
20 14 1 0
19 21 1 0
21 22 3 0
7 23 1 0
23 2 1 0
23 24 1 1
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.49Molecular Weight (Monoisotopic): 390.2056AlogP: 4.53#Rotatable Bonds: 3Polar Surface Area: 92.24Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.48CX LogP: 3.97CX LogD: 3.97Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.83Np Likeness Score: -0.16
References 1. Huang H, Guzman-Perez A, Acquaviva L, Berry V, Bregman H, Dovey J, Gunaydin H, Huang X, Huang L, Saffran D, Serafino R, Schneider S, Wilson C, DiMauro EF.. (2013) Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors., 4 (12): [PMID:24900633 ] [10.1021/ml4003315 ] 2. (2016) Oxazolidinone compounds and derivatives thereof,